BIEL (Bioelectronics) Total Stockholders Equity: $0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Bioelectronics Total Stockholders Equity?

Bioelectronics BIEL +6.06% Total Stockholders Equity is $0.00 Mil as of . 20.

Bioelectronics's Total Stockholders Equity for the quarter that ended in . 20 was $0.00 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Bioelectronics's Book Value per Share for the quarter that ended in . 20 was $N/A. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Bioelectronics's Debt-to-Equity for the quarter that ended in . 20 was .

Bioelectronics  (OTCPK:BIEL) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Bioelectronics's Book Value per Share for the quarter that ended in . 20 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-)/0
=N/A

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Bioelectronics's Debt-to-Equity for the quarter that ended in . 20 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=( + ) /
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioelectronics Total Stockholders Equity Related Terms

Bioelectronics Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Bioelectronics's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioelectronics Total Stockholders Equity Chart

Bioelectronics Annual Data
Trend
Total Stockholders Equity

Bioelectronics Semi-Annual Data
Total Stockholders Equity
What does a Total Stockholders Equity of $0.00 Mil mean?
Bioelectronics (BIEL) has a Total Stockholders Equity of $0.00 Mil as of . 20. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Bioelectronics and its competitors.
Is Bioelectronics' Total Stockholders Equity too high?
Bioelectronics' current Total Stockholders Equity is $0.00 Mil.
How does Bioelectronics' Total Stockholders Equity compare to NUVPF and ADMD?
Bioelectronics' Total Stockholders Equity of $0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Medical Devices & Instruments company?
A good Total Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Bioelectronics and its competitors. Bioelectronics's current Total Stockholders Equity is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioelectronics stock overvalued right now?
Bioelectronics (BIEL) has a current Total Stockholders Equity of $0.00 Mil. The current Total Stockholders Equity is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Bioelectronics (BIEL), the current Total Stockholders Equity is $0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bioelectronics Business Description

Address 3880 Roundtree Road, Suite 1, Jefferson, MD, USA, 21755
Bioelectronics Corp is an electroceutical company. The company develops wearable, neuromodulation devices to safely mitigate neurological diseases and improve quality of life. Its product line includes Actipatch Musculoskeletal Pain Therapy, Allay menstrual pain therapy, Smart insole heel pain therapy, and Recovery RX post operative and Chronic wounds therapy. It sells its products to wholesale distributors, directly to hospitals and clinics, and to consumers. develops & commercializes electrical stimulation/neuromodulation technology. Company products include RecoveryRx, ActiPatch Musculoskeletal Pain Relief, and Others.